Clinical Trials Logo

Clinical Trial Summary

Lactulose HMBT and Glucose HMBT are simple non-invasive tests to assess whether imbalances in gut bacteria may be contributing to troublesome tummy symptoms. These imbalances in gut bacteria include small intestinal bacterial overgrowth (SIBO) and excessive methane production. Recently there has been a lot of work to done by experts in the field, to ensure that performance and interpretation of these tests are standardised, to help improve the clinical utility of these investigations. Although there is a lot of information currently available demonstrating the risk factors and symptoms associated with these conditions, there is a lack of data demonstrating the factors that might lead to a positive test according to these new parameters. This study aims to collect data on symptoms and medical history, in patients referred for lactulose and glucose HMBT in order further improve the effectiveness of this test in the future.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Small Intestinal Bacterial Overgrowth

NCT number NCT05122520
Study type Observational
Source The Functional Gut Clinic
Contact Anthony Hobson
Phone 01613027777
Email [email protected]
Status Recruiting
Phase
Start date February 10, 2021
Completion date December 11, 2023

See also
  Status Clinical Trial Phase
Completed NCT03318614 - Bifidobacterium Infantis M-63 Improves Mental Health in Irritable Bowel Syndrome Developed After a Major Flood Disaster Phase 2/Phase 3
Completed NCT02251483 - Use of SBI in IBS Subjects Following a Successful Treatment of Small Intestinal Bacterial Overgrowth N/A
Recruiting NCT04244877 - Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotility Phase 3
Completed NCT00680836 - Gulf War Digestive Health Study N/A
Enrolling by invitation NCT03659175 - Characteristic of Intestinal Flora in Male Elderly With Small Intestinal Bacterial Overgrowth
Recruiting NCT04506593 - Indiana University Gastrointestinal Motility Diagnosis Registry
Recruiting NCT04316806 - Effect of a Probiotic Formula on Reducing SIBO in IBS Patients N/A
Recruiting NCT04501380 - Efficacy of AEMCOLO (Rifamycin SV MMX) in the Treatment of Small Intestinal Bacterial Overgrowth (SIBO) Phase 2
Completed NCT03692299 - Effectiveness of Saccharomyces Boulardii for Gastrointestinal Bacterial-overgrowth in Systemic Sclerosis Phase 4
Not yet recruiting NCT04910815 - Feasibility of a New Diagnostic Device to Assess Small Intestinal Dysbiosis in Routine Clinical Setting. N/A
Recruiting NCT04499742 - Comparative Assessment of Radioisotope Glucose and Breath Test
Enrolling by invitation NCT02458781 - Antibiotic Treatment Trial for Small Intestinal Bacterial Overgrowth Phase 4
Enrolling by invitation NCT01822470 - Small Intestinal Bacterial Overgrowth: A Prospective Registry
Suspended NCT02439307 - Effycacy of Rifaximin on Reverse Minimal Hepatic Encephalopathy and Elimation Small Intestinal Bacterial N/A
Completed NCT03216239 - SIBO & SIFO After Colectomy
Completed NCT00619970 - Is Chronic Abdominal Pain in Pediatric Patients Due to Small Intestinal Bacterial Overgrowth? N/A
Recruiting NCT03588845 - The Small Intestine Bacterial Overgrowth Study Pilot N/A
Withdrawn NCT03420976 - Novel Supplement-based Therapy for the Treatment of Small Intestinal Bacterial Overgrowth Early Phase 1
Completed NCT02470780 - Treating Bacterial Overgrowth in Parkinson's Disease Phase 2/Phase 3
Completed NCT03261856 - Clinical Utility of Breath Tests in GI